New scan could pinpoint returning prostate cancer
Diagnosis
Completed
This Phase 3 study tested a radioactive tracer called Copper Cu 64 PSMA I&T, given as an injection, to improve PET/CT scans in 235 men with prostate cancer that may have returned after initial treatment (surgery or radiation). The goal was to see how accurately the scan could det…
Phase: PHASE3 • Sponsor: Curium US LLC • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC